key: cord-0938264-i6z3pexa authors: Cardenas, Nicky C title: Advancing strategic policy on European Union digital COVID-19 certificate date: 2021-06-17 journal: J Public Health (Oxf) DOI: 10.1093/pubmed/fdab227 sha: 1d97dde4fac690e8251cdea4983c3c6a4a2cfc56 doc_id: 938264 cord_uid: i6z3pexa nan On 15 April 2021, the World Health Organization (WHO) Director-General under the International Health Regulations (2005) (IHR) convened at the seventh meeting of the Emergency Committee regarding COVID-19 pandemic. The committee concurred that, 'COVID-19 pandemic remains a public health emergency of international concern (PHEIC) and o ered advice to the Director-General.' 1 The committee emphasized the specific urgent need for strategic enhancement of health measures in relation to international tra c. With this, in the context of international travel, it advised WHO to update constantly WHO interim position regarding proof of vaccination, interim guidance, tools related to standardization of paper and digitalization of COVID-19 travel risk-reduction measures. In a recent correspondence in this journal, the author indicated that, 'vaccine hesitancy may be experienced by the more educated sectors and/or individuals from developing countries who travel to Europe for work or leisure due to lack of equitable access to European Medicines Agency (EMA)approved vaccines.' 2 The author posed critical vaccine passport concerns whereby educators/individuals who reside in COVID-19 high-risk and hard-hit countries, are constrained to accept any available non-EMA approved vaccines. This raises issue on freedom of movement and discrimination in the international tra c not only among educators/individuals, but also including international students too who direly need to enter into Europe for academic purpose. Thus, this paper proposes to the European national governments to enhance 'coordinated approach' toward safe and free movement beyond borders during COVID-19 among essential and selected or limited non-essential thirdcountry travelers by lifting restrictions to any person who could provide proof either 'vaccinated by EMA-approved jabs or WHO-approved jabs for Emergency Use Listing (EUL) in the COVAX facility supply, such as Sinovac's CoronaVac and among others that await for EMA and EUL approval. Sinovac's CoronaVac was recently approved by WHO for EUL with assurance that it meets international standards for safety, e cacy and manufacturing.' 3 Millions of people have been vaccinated in many developing countries. It would be a strategic approach for Europe to lead by example and show the world how it governs with impartiality, solidarity and inclusiveness to lift restrictions for international travelers fully vaccinated by Sinovac's CoronaVac from various developing countries that do not have equitable access to EMA-approved jabs, especially international students who need to travel to Europe. European national governments may consider other health reduction-risk measures as alternative viable strategy if appropriate. The 'Council's Permanent Representatives Committee' (Coreper) supported unanimously to the political agreement reached with the European Parliament on 20 May on the EU digital COVID certificate for the purpose of 'safe and free movement during COVID-19 pandemic among EU member states.' A person is required to provide proof of either 'vaccinated by EMA-approved jabs, received a negative test result or recovered from COVID-19.' 4 In addition, European Council reiterated that, 'if member states accept proof of vaccination to waive travel restrictions such as testing or quarantine, they should in principle lift restrictions on nonessential travel for third-country travelers who received an EMA approved vaccine and WHO-approved vaccines for EUL, both at least 14 days before arrival.' 5 Importantly, WHO recently confirmed that, 'national authorities and conveyance operators should not introduce requirements of proof of COVID-19 vaccination for international travel as a condition for departure or entry at the moment for lack of evidence concerning the e cacy of vaccination in reducing transmission.' 6 However, it noted the significance of technological considerations on the establishment of strategic digital COVID-19 certificate among international travelers in the future to record their COVID-19 vaccination status through the 'International Certificate for Vaccination and Prophylaxis' based on the model presented pursuant to IHR. This implies that Europe is advancing good leadership by utilizing EU digital certificate on COVID-19 vaccination program but it must address gaps on scientific, ethical and legal aspects. Combatting COVID-19 needs careful long-term, coordinated, concrete and strategic policy-making and implementation toward successful 'digital-based approach' for e cient health measures in the international tra c and international border control measures in containment and mitigation of COVID-19 and new variants of concerns surge. Therefore, this paper concludes that EU-WHO should step in to leverage strategic international cooperation for advancing 'governance framework and specifications, digital functionality and systems architecture' of digital COVID-19 certificate with considerations on 'scientific, ethical and legal' aspects in the near future once COVID-19 vaccines are universally available. the-seventh-meeti ng-of-the-international-health-regulations-(2005)-emergency-commi ttee-regarding-the-coronavirus-disease-(covid-19)-pandemic Inoculation now or later? Lower e cacy and vaccine passport concerns WHO Validates Sinovac COVID-19 Vaccine for Emergency Use and Issues Interim Policy Recommendations COVID-19: Coreper Endorses Political Agreement on the EU Digital COVID Certificate to Facilitate Free Movement COVID-19: Council Updates Recommendation on Restrictions to Travel from Third Countries Interim Position Paper: Considerations Regarding Proof of COVID-19 Vaccination for International Travellers No funding was received in this paper. The author declares no conflict of interest.